(Q53365410)

English

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

focal segmental glomerulosclerosis

1 reference

based on heuristic

inferred from title

author name string

P Tarshish

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

J N Tobin

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

J Bernstein

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

C M Edelmann

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

publication date

1 October 1996

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

Pediatric Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

590-593

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

Primary focal segmental glomerulosclerosis: clinical course and response to therapy

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Treatment of severe nephrotic syndrome with meclofenamate: an uncontrolled pilot study.

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children.

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Long-Term Evaluation of Children with Nephrotic Syndrome and Focal Segmental Glomerular Sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS004670050167

21 January 2018

Focal segmental glomerulosclerosis with and without nephrotic syndrome in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term prognosis of patients with focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of azathioprine in children with nephrotic syndrome. A report for the international study of kidney disease in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary nephrosis in childhood associated with focal glomerular sclerosis: is long-term prognosis that severe?

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of severe childhood nephrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Editorial: Focal glomerular sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal segmental glomerulosclerosis with rapid decline in renal function ("malignant FSGS")

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison between pre- and posttreatment renal biopsies in children receiving ciclosporine for idiopathic nephrosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal segmental glomerulosclerosis (FSG) 20 years later. From toddler to grown up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. A report of the Southwest Pediatric Nephrology Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Focal and segmental hyalinosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8897562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S004670050167

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/8897562

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53365410&oldid=2212093036"